The Clinical Value of Cardiac PET in Heart Failure
Author:
Ko Chi-Lun,Wu Yen-Wen
Reference44 articles.
1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. doi:
10.1016/j.jacc.2013.05.019
. 2. Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med: Off Publ Soc Nucl Med. 2014;55(9):1438–44. doi:
10.2967/jnumed.114.141093
. 3. Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518–27. doi:
10.1161/circulationaha.113.008507
. 4. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19–27. doi:
10.1161/circulationaha.114.011939
. 5. Wu YW, Chen YH, Wang SS, Jui HY, Yen RF, Tzen KY, et al. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients. J Nucl Med: Off Publ Soc Nucl Med. 2010;51(6):906–12. doi:
10.2967/jnumed.109.073833
.
|
|